Trials / Completed
CompletedNCT06323395
Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye
Multi-centre, Randomised,Parallel-group, Controlled (Placebo), Double-blind Study to Evaluate the Efficacy, Ocular Tolerability and Safety of Vizol S Lipid Balance in the Adult Patient Population With Moderate to Severe Dry Eye for up to 30 Days
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Jadran Galenski laboratorij d.d. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The clinical investigation was intended to investigate the efficacy, ocular tolerability and safety of Vizol S Lipid Balance, a new eye drops, emulsion developed by JADRAN - GALENSKI LABORATORIJ d.d., in patients with moderate to severe evaporative DED after a treatment for 30 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vizol S LIPID BALANCE eye drops | 1 drop 4 times a day |
| DRUG | ophthalmic saline eye drops | 1 drop 4 times a day |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2024-03-21
- Last updated
- 2024-03-21
Locations
2 sites across 1 country: Serbia
Source: ClinicalTrials.gov record NCT06323395. Inclusion in this directory is not an endorsement.